HEPATOCELLULAR CARCINOMA AND IMAGING IN CLINICAL TRIALS
Hepatocellular Carcinoma (HCC) is the most common malignancy of the liver (75% to 95% of all primary liver cancer) and the sixth most common cancer worldwide. Most tumors develop in patients with chronic liver disease and cirrhosis.
Hepatocellular carcinoma (HCC) is one of the most common and deadly liver cancers worldwide. In this eBook, we detail the vital role of imaging in HCC clinical trials, highlighting techniques for evaluating tumor response and the use of selective internal radiation therapy (SIRT). It also showcases our expertise in supporting imaging for HCC research.